Vascular grafts market seen reaching $5.35 billion by 2030

The vascular grafts market is projected to grow from $3.86 billion in 2025 to $5.35 billion by 2030, driven by rising cardiovascular disease, more bypass surgeries and newer graft technologies. North America led the market in 2025, while bioengineered and AI-assisted grafts are shaping the next phase of growth.

Why it matters: - Vascular grafts are central to surgery for blocked or damaged blood vessels. - Rising cardiovascular disease rates are increasing demand for bypass and vessel-repair procedures. - The market outlook points to steady growth through 2030, which matters for device makers, hospitals and surgical innovation.

What happened: - The Business Research Company released a market analysis projecting the vascular grafts market will rise from $3.86 billion in 2025 to $4.1 billion in 2026. - The report forecasts the market will reach $5.35 billion by 2030. - The projection implies a 6.1% CAGR from 2025 to 2026 and a 6.9% CAGR over the forecast period to 2030. - North America held the largest share of the market in 2025. - Western Europe ranked second in 2025.

The details: - Vascular grafts are used in bypass surgery to reconnect blood vessels around partial or complete arterial blockages. - The procedure restores blood flow by rerouting circulation from one area of the body to another. - Growth drivers include more cardiovascular disease cases, more frequent bypass surgeries, advances in synthetic and biological graft materials, and expanded hospital and cardiac surgery infrastructure. - The forecast also reflects growing awareness of vascular disorders. - The report highlights tissue-engineered grafts, AI-driven personalized graft designs, minimally invasive surgical techniques, intraoperative imaging integration and an aging population as key growth factors. - Expected trends include bioengineered grafts, AI-assisted design, minimally invasive implantation, enhanced imaging integration and patient-specific customization. - The report covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa in addition to North America and Western Europe. - The Centers for Disease Control reported that in 2023 about 919,032 people in the US died from cardiovascular disease, accounting for one out of every three deaths.

Between the lines: - The report points to a shift from standard graft materials toward more customized and technology-enabled solutions. - AI and imaging integration suggest future competition will center on precision, surgical efficiency and patient-specific outcomes. - The aging population adds a structural demand tailwind that is less likely to reverse quickly.

What's next: - The market is likely to keep expanding as hospitals adopt newer graft materials and minimally invasive techniques. - Tissue-engineered and bioengineered grafts appear positioned as the next major product category to watch. - The report also points to continued regional opportunities beyond North America, especially in emerging healthcare markets. - The full report is available here. - A free sample is available here.

The bottom line: - Vascular grafts are moving from a mature surgical supply category toward a higher-growth market shaped by cardiovascular demand, personalization and advanced materials.